Skip to content

Solutions For Immunoassays and In Vitro Immunodiagnostics

Home
Company
COVID-19
Services
Support
News
Contact

Quote Request

Shopping cart

Latest news

FDA has acknowledged receipt of the request and assigned an EUA number On May 16, 2020
FDA has acknowledged receipt of the request and assigned a pre-EUA number On May 7, 2020
dAb ImmunoTech Announced Development of SARS-CoV-2 (COVID-19) IgG and IgM Dual Antibody Test

Upcoming events

Antibody Engineering & Therapeutics, San Diego, CA, December 13-17, 2020

Coronavirus (COVID-19) Update: Daily Roundup

China: From Crisis to Recovery

COVID-19 Response

Find out more

Selecting the Right Multiplex Immunoassay Technology

Coronavirus latest: global infections pass 379 million

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Partnership

Become a partner for global business

Solutions For Immunoassays and In Vitro Immunodiagnostics

About

dAb ImmunoTech applies innovative immunoassay technology to focus on developing essential reagents and kits for research and in vitro Diagnostics of cancer and infectious diseases.

dAb ImmunoTech

Home
Company
COVID-19
Services
Support
News
Contact

Contact Info

	General Inquiries info@dabimmunotech.com
	Business Inquiries business@dabimmunotech.com
	+1-470-556-1748
	dAb ImmunoTech Headquarters 11555 Medlock Bridge Road Johns Creek, GA 30097 USA Lab & Manufacture Facilities 1860 Montreal Road Tucker, GA 30084 USA

Copyright © 2026 dAb ImmunoTech. All rights reserved.